Safety of efalizumab in patients with psoriatic arthritis: results of a phase II, randomized, double-blind, placebo-controlled study
- 31 March 2004
- journal article
- abstracts
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 50 (3) , P156
- https://doi.org/10.1016/j.jaad.2003.10.550
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: